Primary objectives:
* To estimate Sexual Dysfunction (SD) incidence in premenopausal breast cancer patients treated by surgery and taking endocrine therapy. * To detect the presence of SD-related distress in the population, as a determining factor in the maintenance of a good quality of life.
Secondary objectives:
* To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens. * Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population.
women aged ≥18 and ≤ 55
who underwent surgery for early stage breast cancer
taking endocrine therapy for at least 3 months
providing an informed consent and completing the study questionnaires.
withdrawal of the informed consent, at any time
Women aged ≥18 and ≤ 55 who underwent surgery for early stage breast cancer, taking endocrine therapy for at least 3 months
Cohort
Cross-sectional
Questionnaire
Other interventionnone, it's a incidence-prevalence study
Sexual Dysfunction (SD) incidence
To estimate Sexual Dysfunction (SD) incidence (physiological parameter) in premenopausal breast cancer patients treated by surgery and taking endocrine therapy.
SD-related distress
To detect the presence of SD-related distress (physiological parameter) in the population, as a determining factor in the maintenance of a good quality of life.
SD characteristics
To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens.
Collect baseline data
Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population.
Click on the lead sponsor to view all of their trials.
